These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prospective validation of a novel renal activity index of lupus nephritis. Gulati G; Bennett MR; Abulaban K; Song H; Zhang X; Ma Q; Brodsky SV; Nadasdy T; Haffner C; Wiley K; Ardoin SP; Devarajan P; Ying J; Rovin BH; Brunner HI Lupus; 2017 Aug; 26(9):927-936. PubMed ID: 28361601 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review. Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S Am J Nephrol; 2021; 52(7):559-571. PubMed ID: 34515043 [TBL] [Abstract][Full Text] [Related]
7. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
8. Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis. Akhgar A; Sinibaldi D; Zeng L; Farris AB; Cobb J; Battle M; Chain D; Cann JA; Illei GG; Lim SS; White WI Lupus Sci Med; 2023 Jan; 10(1):. PubMed ID: 36717181 [TBL] [Abstract][Full Text] [Related]
9. A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis. Landolt-Marticorena C; Prokopec SD; Morrison S; Noamani B; Bonilla D; Reich H; Scholey J; Avila-Casado C; Fortin PR; Boutros PC; Wither J Arthritis Res Ther; 2016 Oct; 18(1):218. PubMed ID: 27716443 [TBL] [Abstract][Full Text] [Related]
10. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis. Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A Front Immunol; 2020; 11():256. PubMed ID: 32265898 [TBL] [Abstract][Full Text] [Related]
11. Nuclear magnetic resonance-based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis. Ganguly S; Kumar U; Gupta N; Guleria A; Majumdar S; Phatak S; Chaurasia S; Kumar S; Aggarwal A; Kumar D; Misra R Lupus; 2020 Jun; 29(7):782-786. PubMed ID: 32299281 [TBL] [Abstract][Full Text] [Related]
12. Targeted urine proteomics in lupus nephritis - a meta-analysis. Zhang T; Duran V; Vanarsa K; Mohan C Expert Rev Proteomics; 2020 Oct; 17(10):767-776. PubMed ID: 33423575 [TBL] [Abstract][Full Text] [Related]
13. The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients. Liu L; Wang R; Ding H; Tian L; Gao T; Bao C PLoS One; 2020; 15(10):e0240942. PubMed ID: 33108403 [TBL] [Abstract][Full Text] [Related]
14. Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis. Jakiela B; Kosałka J; Plutecka H; Węgrzyn AS; Bazan-Socha S; Sanak M; Musiał J Lupus; 2018 Jul; 27(8):1259-1270. PubMed ID: 29653499 [TBL] [Abstract][Full Text] [Related]
15. Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL). Bennett MR; Ma Q; Ying J; Devarajan P; Brunner H Pediatr Rheumatol Online J; 2017 Oct; 15(1):74. PubMed ID: 29029629 [TBL] [Abstract][Full Text] [Related]